>The top five minimally-invasive procedures were Botox (3.8 million)…<
Good write-up, Dubi. The Botox cosmetic-procedure count is hard to track, so I don’t take the number in the article too seriously. There are two reasons for this: 1) The same Botox product is ordered for either cosmetic or therapeutic purposes (sales are approximately 60% therapeutic, 40% cosmetic); and 2) A single vial is frequently split among several cosmetic patients, provided that they have consecutive appointments. (Botox remains potent for approximately four hours after being reconstituted by the injector.)
>This is the first time in six years facelifts did not make the top five [cosmetic] surgical procedures, according to ASPS statistics.<
It’s unlikely that facelifts will ever again rank among the top-5. The whole point of the array of new filler products to produce near-facelift-like results without surgery. Regards, Dew
Market Data 
Markets 
AI
